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1 
Abstract 
Antimicrobial resistance is a global public health crisis and a national security threat to the United States, as 
stated in an Executive Order signed by the President in September 2014.  This crisis is a result of 
indiscriminant antimicrobial use, which promotes selection for resistant organisms, increases the risk of 
adverse drug events and renders patients vulnerable to drug-resistant infections.  Antimicrobial stewardship is 
a key measure to combat antimicrobial resistance and specifically seeks to do this by improving antimicrobial 
use.  Antimicrobial stewardship compliments infection control practices and it is important to note that these 
two disciplines are distinct and cannot be discussed interchangeably.  Antimicrobial stewardship promotes the 
appropriate diagnosis, drug, dose, and duration of treatment.  The appropriate diagnosis falls into the hands of 
the prescriber and clinical staff.  Optimal antimicrobial drug selection, dosing strategy, and duration of 
treatment, however, often require expertise in antimicrobial therapy, such as an infectious disease trained 
physician or pharmacist.  Therefore, successful antimicrobial stewardship programs must be comprehensive 
and interdisciplinary.  Most antimicrobial stewardship programs focus on hospitals yet, in long-term care, up to 
75% of antimicrobial use is inappropriate or unnecessary.  Therefore, one of the most pressing areas in need 
for antimicrobial stewardship is in long-term care facilities.  Unfortunately, there is little evidence that describes 
effective antimicrobial stewardship interventions in this setting.  This review discusses the need for and barriers 
to antimicrobial stewardship in long-term care facilities.  Additionally, this review describes prior interventions 
that have been implemented and tested to improve antimicrobial use in long-term care facilities. 
 
Keywords. antimicrobial stewardship program; antimicrobial resistance; long-term care; nursing home; 
antibiotic use 
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Introduction 
Antimicrobial resistance is one of the greatest public health threats in the United States, prompting the 
President of the United States, the enters for Disease Control and Prevention (CDC) and the World Health 
Organization to spearhead initiatives seeking effective solutions.1-3  The prevalence of antimicrobial-resistant 
organisms is increasing throughout the United States (US), as is the use of "last line" and toxic antibiotics to 
treat infections caused by resistant bacteria.4  The driving force that selects for antimicrobial-resistant bacteria 
and promotes Clostridium difficile (C. difficile) infection is antimicrobial use.1  Approximately 50% of 
antimicrobial use in hospitals and up to 75% of antibiotic use in long-term care facilities may be inappropriate 
or unnecessary.5,6  As such, it is critically important to the safety of patients that antimicrobial use is improved 
throughout the entire healthcare system.  Antimicrobial stewardship is typically defined as any activity to 
improve the drug, dose, duration or route of an antimicrobial.7  However, stewardship should also focus on an 
appropriate diagnosis.  The primary goal of antibiotic stewardship is to optimize clinical outcomes while 
minimizing unintended consequences of antimicrobial use. 
 
Implementation of new antimicrobial stewardship programs is challenging, requiring increased resources and 
time.  Despite this, implementation of antimicrobial stewardship programs has been recommended for all 
healthcare settings in the US, including long-term care facilities.7,8  According to the CDC, over the next five 
years, approximately 619,000 infections due to resistant pathogens and C. difficile could be prevented with the 
immediate and national implementation of antibiotic stewardship and infection control interventions,.9  In acute 
care facilities, comprehensive antimicrobial stewardship programs have been shown to improve the quality of 
patient care and safety.  Through reduction of inappropriate antibiotic use and optimization of antimicrobial 
therapy, antimicrobial stewardship programs can reduce rates of C. difficile infection and slow the emergence 
of antimicrobial resistance.10-12  However, applying the evidence-based principles of antimicrobial stewardship 
developed in acute care facilities to long-term care facilities, presents significant challenges.7 
 
In an effort to support improved antimicrobial use, the Obama administration recently released an Executive 
Order (September 2014) and a National Action Plan (March 2015) for combating antibiotic-resistant 
bacteria.3,13  This plan specifically calls for strengthening antibiotic stewardship in long-term care settings “by 
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expanding existing programs, developing new ones, and monitoring progress and efficacy”.3  Additionally, for 
the first time since 1991, Centers for Medicare and Medicaid service (CMS) has now opened for comments 
their new proposed rules for long-term care facilities.  Proposed recommendations include: 1) a required 
infection prevention and control officer, and 2) an antibiotic stewardship program that includes antibiotic use 
protocols and a system to monitor antibiotic use.  Additionally, the CDC recently released seven Core 
Elements of antimicrobial stewardship in long-term care facilities, including 1) facility leadership commitment, 
2) accountability, 3) drug expertise, 4) actions to improve use, 5) education, 6) tracking and 7) reporting.14  
While progressive, these recommendations face many challenges, particularly due to the paucity of evidence 
on effective antimicrobial stewardship practices in long-term care.  Here, to help advance these efforts, we 
review the literature describing antimicrobial stewardship efforts in long-term care.  Specifically, we discuss the 
need for and barriers to antimicrobial stewardship in long-term care facilities as well as prior strategies that 
have been implemented to improve antimicrobial use in this unique setting.  
 
Methods 
We conducted a structured review of existing literature related to antimicrobial stewardship in long-term care 
facilities.  This review was conducted to identify: 1) the need for antimicrobial stewardship in long-term care 
facilities, 2) barriers to antimicrobial stewardship in long-term care facilities, and 3) prior studies related to 
implementation of antimicrobial stewardship interventions in long-term care facilities.  We used Medline to 
perform the structured search using the following relevant key words: antimicrobial stewardship, antimicrobial 
use, long-term care facility and nursing home.  References in English dated between 1966 and June 2015 
were considered.  We also conducted a follow up Internet Search and search of reference lists from relevant 
studies.  Based on a review of titles and abstracts, documents were selected for full text review if they fell in to 
one of the three categories above.  All documents selected for full-text review were included in our review 
article.  In order to describe and synthesize intervention literature, the following were collected from each 
article: year of publication, infection type, study design, study setting, intervention, unit of analysis, and major 
findings.  
 
Results 
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We selected 67 articles for inclusion based on full text review.  Of these, 30 (44.8%) articles were categorized 
as needs for antimicrobial stewardship, 26 (38.8%) as barriers to antimicrobial stewardship, and 15 (22.4%) as 
prior studies related to implementation of antimicrobial stewardship interventions in long-term care facilities.  
Four (6.0%) articles addressed more than one category.  Needs for antimicrobial stewardship in long-term care 
can be found in Table 1.  These articles included 23 (76.7%) observational studies, 5 (16.7%) review articles, 
and 2 (6.7%) professional society guidelines.  Barriers to antimicrobial stewardship in long-term care can be 
found in Table 2.  These articles included 9 (34.6%) review articles, 5 (19.2%) professional society 
guidelines/recommendations, and 4 (15.4%) observational studies. 
 
Prior studies related to implementation of antimicrobial stewardship interventions in long-term care facilities 
can be found in Tables 3 and 4.  These articles include 8 (53.3%) quasi-experimental studies, 5 (33.3%) 
randomized controlled trials, 1 (6.7%) pre- vs. post-intervention survey, and 1 (6.7%) systematic review.  Of 
the articles that tested an intervention (n=14), 78.6% were multifaceted educational interventions.  Studies that 
assessed the impact of interventions on general antibiotic use were most common (n=7, 50.0%), followed by 
interventions that target a specific syndrome (n = 7, 50.0%). 
 
Discussion 
Need for Antimicrobial Stewardship in Long-Term Care Facilities. 
In 2013, approximately 1.4 million adults received nursing home care at one of the over 15,700 facilities in the 
United States.15  As a group, the residents of long-term care facilities represent some of the oldest and frailest 
members in our communities.16  Based on results from the 2004 National Nursing Home Survey, 45% of 
nursing homes residents were aged 85 years and older, with an average length of stay 2.3 years.17  Nearly 
80% were dependent for assistance with at least 4 of the 5 activities of daily living: toileting, bathing, transfer, 
dressing and eating.  Increasing age, frailty, immune senescence, and comorbid conditions render long-term 
care facility residents vulnerable to infection.  Even for experienced clinicians, determining whether a long-term 
care resident has an infection presents significant challenges.  This may contribute to the high prevalence of 
antibiotic use in this population.18,19 
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Inappropriate and Unnecessary Antibiotic Use in Long-Term Care Facilities 
Antimicrobials account for almost half of all prescriptions in long-term care facilities.20,21  It is estimated that 50-
75% of residents receive at least one course of an antibiotic each year.22-24  Unfortunately, many of these 
prescriptions represent overuse or inappropriate use.25  A study of 2 community-based nursing homes in 
Rhode Island found several types of inappropriate antibiotic prescribing patterns related to urinalyses ordered 
on 172 case residents.  Antibiotic treatment was initiated in 70 case residents (41%) that did not meet the 
McGeer criteria.  Additionally, 72% of case residents received an inappropriate drug based on Infectious 
Diseases Society of American criteria, 46% were dosed inappropriately based on creatinine clearance, and 
67% received treatment for longer than recommended.26  A study which reviewed antimicrobial orders from 42 
skilled nursing facilities found that 38% of orders were inappropriate.27  Similarly, in a retrospective chart 
review of systemic antimicrobial regimens administered to residents of a 160-bed Veterans Affairs (VA) skilled 
nursing facility, 43% of the 1,351 days of antimicrobial therapy were deemed unnecessary and 49% of 
residents received at least one day of unnecessary antimicrobial therapy.6  The most common reasons for 
entirely and partially unnecessary regimens were asymptomatic bacteriuria and longer than recommended 
treatment durations, respectively. 
 
Inappropriate antibiotic prescriptions not only originate in the long-term care facility, but also in other settings 
where residents receive care.  For example, a resident may be sent to the emergency department for a 
potentially non-infectious cause such as delirium or agitation, and be sent back to the nursing home with an 
inappropriate antimicrobial prescription.  Additionally, a resident may be discharged from the hospital with an 
antimicrobial prescription that was not indicated, was the wrong drug or dose, or was continued for too long a 
duration.26  A resident may also be prescribed an inappropriate antibiotic at a specialist visit, such as urology, 
rheumatology, dermatology, or even through an infectious diseases consult, all of which may contribute to the 
high prevalence of inappropriate use among long-term care facilities. 
 
Increased Risk for Colonization with Resistant Bacteria 
On average, at least 30-50% of long-term care residents are colonized with one or more resistant organisms 
and colonization can lead to subsequent infection, particularly in older, frail residents.28-34  The primary mode of 
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introduction of resistant organisms into this setting is the transfer of infected or colonized residents from acute 
care hospitals to long-term care facilities.35  Acute care facilities and long-term care facilities are connected 
through shared residents.  A recent study using the Long-Term Care Minimum Data Set revealed a high 
volume of bidirectional flow between long-term care facilities and acute care hospitals.36  During the 15-month 
study period, there were over two million discharges from long-term care facilities to acute care hospitals and 
over four million admissions to long-term care facilities from acute care hospitals.36  As an example, long-term 
care residents in a regional health system in Iowa colonized with vancomycin-resistant enterococci (VRE) were 
significantly more likely than non-colonized residents to have been hospitalized at an acute care facility (19/30 
vs. 12/66; odds ratio [OR], 8.0; 95% confidence interval [CI], 2.7 - 23.8).37  However, long-term care facilities 
residents may be seen as reservoirs of resistant bacteria, and can also transport resistant organisms to the 
acute care setting or into the community.35,38 
 
Methicillin-resistant Staphylococcus aureus (MRSA) colonization among long-term care residents can be as 
high as 60%, as identified in one study among 412 residents at three separate long-term care facilities.31  A 
point prevalence survey of long and short-term acute care facilities in Chicago found the prevalence of those 
colonized with carbapenem-resistant Enterobacteriaceae (CRE) was much higher among residents in long-
term care facilities compared to patients in acute care facilities (30.4% vs. 3.3%).39  Factors that increase the 
risk of colonization with multi-drug resistant organisms relate both to residents health and their environment.  
Exposure to multiple courses of antibiotics select for resistant bacteria.  Other factors that increase the risk of 
colonization by resistant bacteria for long-term care facility residents include poor nutritional status, skin and 
soft-tissue breakdown, and the presence of multiple devices, including gastrostomy tubes and/or indwelling 
catheters.35  In an effort to support a home-like environment, long-term care facilities encourage social 
interaction in shared spaces.  Unfortunately, these practices may increase opportunities for residents to 
disseminate and acquire resistant organisms through shared dining rooms, rehabilitation equipment and 
recreation areas.  Among long-term care residents, independent risk factors found to be associated with 
colonization for multi-drug resistant organisms include, prior colonization or infection by multi-drug resistant 
organisms, hospitalization in the past three months, recurrent urinary tract infections, peripheral arterial 
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disease, current wound management, medical devices in situ, pressure ulcers, advanced dementia, and 
prolonged antibiotic use.32,33 
 
Increased Risk of C. difficile Infections 
C. difficile infections are another major concern in the long-term care environment.40  C. difficile infections are 
endemic in many facilities, despite efforts to manage the burden of C. difficile infections in this setting.41  Up to 
30% of residents treated with antibiotics in long-term care facilities acquire C. difficile.42  Residents in two 
Rhode Island nursing homes who received inappropriate antimicrobials for asymptomatic bacteriuria were 8.5 
times more likely to develop C. difficile infections compared to the rest of the nursing home population (95% CI 
1.7 - 42).26  Though exposure to systemic antibiotics and to C. difficile spores often occurs in acute care 
hospitals, symptom onset may not develop until after the resident is transferred to the nursing home.43  
Importantly, older residents who develop C. difficile infections are more likely to develop severe 
complications.44,45 
 
Older adults, including long-term care residents, are also at increased risk for recurrent disease.46  In 2006, the 
Ohio Department of Public Health mandated reporting of healthcare-onset C. difficile infection, using 
standardized case definitions.46  While the incidence rate of first time C. difficile infection in 2006 was lower in 
long-term care facilities than hospitals (up to 2.9 vs. 7.9 cases per 10,000 patient days), the absolute number 
of C. difficile infections was higher in long-term care facilities (11,200 vs. 7,000 cases).  For recurrent cases, 
the mean number of cases per month was higher in long-term care facilities (358 vs. 108).46  The incidence of 
recurrent cases for long-term care facilities and hospitals was as high as 2.4 cases and 2.0 cases per 10,000 
patient days, respectively, for the reporting period. 
 
Barriers to Antimicrobial Stewardship in Long-Term Care Facilities. 
The prevalence of antimicrobial stewardship (various definitions used) among long-term care facilities varied 
greatly in three large statewide/regional surveys from approximately 25% to 60%.47-49  In our literature review, 
we identified several barriers to formalizing antimicrobial stewardship programs in long-term care (Table 2).  
These barriers are notable and can impede the implementation and success of these programs.  One of the 
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main challenges includes a paucity of well-validated strategies specific to long-term care facilities, as 
evidenced by limited finding of studies to improve antimicrobial use in long-term care facilities (Tables 3 and 4). 
 
In general, in long-term care facilities, a clinical event suggestive of infection, such as a fever, prompts an 
evaluation of the affected resident followed by an antimicrobial prescription., Unfortunately, few people that 
work at nursing homes possess specialized knowledge or access to educational resources on antimicrobial 
use and infection management.50-54  Nurses usually conduct the initial evaluations of residents.50  In many 
facilities, nurses are the only licensed healthcare professionals available on-site 24 hours a day.55  Less than 
20% of nursing homes employ full-time staff physicians.56  Providers are most often off-site, splitting their time 
between other long-term care facilities and office-based practice.  A survey of medical directors found that they 
provide primary care at an average of four facilities, where they spend eight to twelve hours a week providing 
care to residents, while also serving as a medical director to two facilities.56  Therefore, providers must rely on 
nursing staff to assess changes in a resident’s status and then communicate their findings via phone or fax.18  
The timing and quality of these communications, as well as professional practice patterns, often favor 
antimicrobial prescriptions as the “safest”, and often most expedient, course of action.  Physicians at one 
hospital reported that they often prescribe treatment for urinary tract infections without seeing the residents and 
rely on nurses to provide information regarding the signs and symptoms of urinary tract infection.57  Another 
study found that only 44% of residents who received antibiotics had an associated claim for a bedside visit by a 
physician within one day of their prescription.58  
 
Resource Limitations 
Additional barriers include lack of funding and facility resources,.7,19,48  For example, tools to measure antibiotic 
utilization or to develop antibiograms in long-term care have thus far been limited.  Another barrier is that many 
long-term care facilities do not have on-site laboratories, which may delay reporting of organism identification 
and susceptibility results, and any resultant stewardship interventions.59  Additionally, few facilities have on-site 
laboratories or radiologic equipment, thus hindering ready access to many diagnostic tests, such as complete 
blood counts or chest films.  The delays inherent to arranging for these tests may significantly delay the 
clinician’s ability to make a prompt and accurate diagnosis. 
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Need for Diagnostic Criteria and Treatment Pathways: Focus on Urinary Tract Infections 
The proper diagnosis and treatment of infection in residents, is itself a barrier to antimicrobial stewardship.  
Diagnosing infections in older residents can be exceedingly challenging due to many factors, such as comorbid 
disease states, blunted immune response, vague symptoms, cognitive impairment, and high rates of 
colonization with drug-resistant bacteria.50  Suspected urinary tract infections in this population are particularly 
challenging. 
 
In long-term care settings, the most common reason residents receive antimicrobials is concern for a urinary 
tract infection (UTI).60-63  Diagnostic criteria for UTIs includes acute dysuria, fever, leukocytosis, and symptoms 
that localize to the urinary tract along with bacterial growth from an appropriately collected urine sample.64  
Distinct from UTI is asymptomatic bacteriuria, in which older adults have positive urinalyses and urine cultures 
without any systemic signs or symptoms of illness (also referred to as “dirty urine”).65  The prevalence of 
asymptomatic bacteriuria is high in this population, affecting 15% of community-dwelling older adults and 50% 
of long-term care facility residents.65   Some healthcare providers respond to any positive urine culture from an 
older adult by prescribing antimicrobials, regardless of whether symptoms of a UTI are present, even though 
treatment has not been shown to decrease the incidence of symptomatic urinary tract infections, nor has it 
been associated with a decrease in morbidity or mortality.65  This is concerning because there is a strong 
association between the treatment of asymptomatic bacteriuria and the subsequent emergence of resistant 
organisms.66,67   
 
Treatment of asymptomatic bacteriuria is especially problematic in residents with indwelling urinary catheters.  
In a cross-sectional study of antibiotic prescription data for residents from four nursing homes in Texas, the 
strongest predictor of antibiotic treatment for asymptomatic bacteriuria was the presence of an indwelling 
urinary catheter.68  For residents with urinary catheters, more than 80% of the antibiotics prescribed were for 
asymptomatic bacteriuria.  In residents without a catheter, approximately 50% of prescriptions were for 
residents with no documented UTI symptoms.  Alarmingly, multivariate analyses demonstrated that resident 
characteristics did not affect whether an antibiotic was prescribed for asymptomatic bacteriuria.  Moreover, the 
10 
only significant factor identified was the nursing home itself.  This evidence suggests that the practices of 
providers may drive treatment for suspected urinary tract infections, rather than the clinical characteristics and 
symptoms of the resident.  Thus, efforts to improve prescriber practices in regards to the treatment of 
suspected urinary tract infections may be an important focus of antimicrobial stewardship interventions in long-
term care facilities. 
  
Lack of trained infectious diseases physicians and pharmacists 
Formal training in infectious diseases and/or antibiotic stewardship is recommended for antimicrobial 
stewardship program leaders.7,69  However, few formal residency and fellowship programs provide specialized 
training in antimicrobial stewardship for physicians and pharmacists.53,54  A recent survey of long-term care 
facilities in Rhode Island demonstrated that approximately 80% of facilities did not have any full-time 
equivalent infectious diseases physicians or pharmacist facility-wide.49  
 
Resident and Family Expectations 
Efforts to promote the judicious use of antibiotics in long-term care may also be hampered by expectations 
from residents and family members.  In a recent prospective cohort study, in 35 Boston-area nursing homes on 
healthcare proxy involvement in decisions on residents with advanced dementia, involvement was associated 
with both increased antibiotic use (adjusted OR 3.43, 95% CI 1.94 - 6.05) and hospital transfer (adjusted OR 
3.00, 95% CI 1.19 - 7.53).73  This trend is likely influenced by a general fear of litigation on the part of the 
provider.  Studies suggest that long-term care physicians often operate in a state of high legal anxiety that may 
prompt more aggressive care and unnecessary transfers out of the nursing home.74  When notified about a 
complex medical resident with nonspecific symptoms, nursing home providers often err on the side of 
caution.75 
 
What works to Improve Appropriate Antimicrobial Use in Long-term Care Facilities? 
Few randomized controlled trials have evaluated interventions to reduce inappropriate antimicrobial use in 
long-term care facilities (Table 3).  A recent systematic review identified only four randomized controlled trials 
designed to reduce inappropriate antimicrobial use in this setting.76  All of these studies provided educational 
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material to physicians and nurses77-79 or to physicians only,80 with two studies also incorporating prescribing 
feedback.79,80  As Table 3 shows, all four studies produced either a decrease in antibiotic utilization or an 
increase in the prevalence of appropriate antibiotic utilization.77-80  However, overall, the quality of evidence 
was weak, the results were mixed and the interventions implemented varied greatly.  Nonetheless, these 
findings support multifaceted interventions, which include educational strategies, as well as locally developed 
guidelines, and prescribing feedback to improve antimicrobial prescribing in the long-term care setting.76  
However, there has been no standardization of programs and multiple components designed to improve 
antimicrobial use are often implemented simultaneously, so the efficacy or effectiveness of any one program 
component is largely unknown.19 
 
Multifaceted Educational Interventions Targeting General Antibiotic Use for All Infection Types 
Antimicrobial stewardship programs that utilize multiple educational modalities have generally been effective at 
improving antimicrobial use for the treatment of both infections in general and specific infection types 
(discussed below)57,81-84 The types of educational interventions and the combinations of stewardship 
interventions assessed to date have varied greatly in the literature (Table 4).  Examples of strategies studied 
include educational sessions, academic detailing, prescribing feedback, and/or dissemination of written 
materials, such as guidelines, algorithms, pocket cards, posters, and toolkits.  
 
Multifaceted educational intervention studies that only target providers have yielded modest results (Table 
4).80,84  The impact of an educational intervention for physicians was assessed in a cluster randomized 
controlled trial among long-term care facilities in Montreal, Canada.80  In intervention facilities, physicians were 
mailed an antibiotic guide and feedback on their prescribing practices over the previous three months.  This 
intervention was then repeated four months later.  By the end of the study, there was a greater decrease in 
antibiotic orders which did not adhere with the guide in the intervention homes versus control (usual care) 
homes (-20.5% vs. -5.1%).  After the second mailing, physicians were 64% less likely to prescribe non-
adherent antibiotics (OR 0.36, 95% CI 0.18 - 0.73), but this effect was not sustained 15 months later (OR 0.48, 
95% CI 0.23 - 1.02).  Similarly, an uncontrolled single-center quasi-experimental study at a public hospital with 
340 long-term care beds assessed the impact of educational sessions with feedback and guidelines on 
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antibiotic use for physicians.84  Post-intervention, 39% of antibiotic use was compliant with guidelines as 
compared to 11% pre-intervention (p<0.001).  During the intervention antimicrobial use and antimicrobial starts 
decreased 29.7% and 25.9%, respectively.  Notably, an interrupted time-series analysis indicated that the 
overall decrease in antimicrobial use persisted for 2 years following the intervention period.  The availability of 
infectious diseases consultations at this long-term care facility may have contributed to the longevity of the 
success of this intervention. 
 
Due to the significant role nurses play in recognizing, assessing and monitoring residents with infections, 
nurses may be an important target for educational interventions aimed at improving antimicrobial use in long-
term care facilities.  The impact of a multifaceted educational intervention for nurses and physicians was tested 
in a cluster randomized controlled trial among 58 nursing homes in Sweden.79  The main components of the 
intervention included small group educational sessions for nurses and physicians, feedback on prescribing, 
presentation of guidelines and written materials.  While there was no significant impact on the primary 
outcome, proportion of quinolones prescribed for lower urinary tract infection, the intervention did achieve a 
significant reduction in the proportion of infections treated with antibiotics (absolute risk reduction [ARR] -0.124, 
95% CI -0.228 - -0.019) and a significant increase in the proportion of infections handled by physicians as “wait 
and see” (ARR 0.143, 95% CI 0.047 - 0.240).  Similarly, a quality improvement program which included 
educational sessions to providers and nurses, a medical care referral form, prescriber feedback, and education 
for staff, residents and families was associated with a significant reduction in antibiotic prescribing rates for all 
indications assessed.83 
 
Educational and Academic Detailing Interventions Targeting Pneumonia 
Multifaceted educational interventions targeting pneumonia have had only a limited impact on improving 
antibiotic use (Table 4).  Three studies have assessed the impact of implementing nursing home-acquired 
pneumonia (NHAP) guidelines through educational programs.78,85,86 Two of these studies, which both assessed 
the impact of educational sessions for nurses and academic detailing to physicians failed to demonstrate 
improvement in antimicrobial use.85,86  A controlled, quasi-experimental study in two state Veterans Homes 
found guideline adherence with respect to choice and timing of antibiotics did not improve significantly post-
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intervention at the intervention facility.85  However, this study did find guideline adherence for these measures 
was higher at the intervention facility as compared to the control facility, during the intervention period.   
 
The second study used a controlled quasi-experimental design among 16 nursing homes in Colorado and 
Kansas to assess the impact of a multifaceted intervention to improve adherence to the NHAP guidelines.86  
The intervention included educational sessions for nurses to improve recognition of pneumonia symptoms and 
timing of antibiotics and academic detailing to prescribers by pharmacists regarding diagnostic and treatment 
practices over the influenza seasons (October to April) of 2005/2006 and 2006/2007.  This study found no 
significant impact on guideline adherence for choice of antibiotic or duration; however improvements in 
adherence to timely antibiotics were significantly higher in intervention homes compared to control homes.  
Neither study found improvements in clinical outcomes, such as mortality and hospitalization rates, post-
intervention.  The impact of these interventions may have been higher if: 1) education had also been provided 
to nurses, (2) academic detailing had been facilitated by a multidisciplinary team, (3) the intervention period  
had been longer in duration, or 4) education had been provided to residents and family members or caregivers.   
 
The third study, a randomized controlled study among ten skilled nursing facilities, assessed the impact of 
small-group education for providers only versus providers and nurses.78  The proportion of antibiotic use 
meeting guidelines (pre- 50% vs. post- 81.8%, p=0.06) improved with the multidisciplinary intervention which 
targeted both providers and nurses, while the physician-only intervention did not have a significant effect (pre- 
64.5% vs. post- 69%, p=0.73).  However, in multivariate analysis, treatment according to the guidelines was 
not significantly different between the multidisciplinary and physician-only intervention groups.  This study 
similarly found no significant differences in overall antibiotic use, mortality or hospitalization rates. 
 
Education to Prevent Misdiagnosis and Overtreatment of Presumed Urinary Tract Infections 
Interventions to improve antimicrobial use for presumed urinary tract infections have generally demonstrated 
greater success than those targeting pneumonia (Table 4).  A cluster randomized controlled trial assessed the 
impact of a multifaceted intervention targeting suspected urinary tract infections on intervention and control 
nursing homes in Ontario, Canada.77  A diagnostic and treatment algorithm for urinary tract infections was 
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implemented using multiple modalities including, small group educational sessions for nurses, videotapes, 
written materials, outreach visits and interviews with physicians.  This intervention was associated with 
significant improvements in antimicrobial prescriptions for suspected urinary tract infections (pre- 1.59 vs. post- 
1.17 courses per 1,000 resident days; weighted mean difference -0.49, 95% CI -0.93 - -0.06) and a non-
significant reduction in urine cultures obtained (pre- 2.48 vs. post- 2.03 cultures per 1,000 resident days; 
weighted mean difference -0.51, 95% CI  -1.38 – 0.35).  Unfortunately, the effect on antimicrobial prescriptions 
was not sustained during a 12-month post-intervention observation period.  Additionally, the study did not 
report significant differences in mortality or hospital admissions.   
 
An uncontrolled quasi-experimental study assessed the effect of a multifaceted educational intervention, which 
included individualized direct feedback for nurses and providers, to reduce inappropriate treatment of 
asymptomatic bacteriuria.57  The rate of treatment of asymptomatic bacteriuria (pre- 1.7 to post- 0.6 
asymptomatic bacteriuria treated per 1,000 resident days; incidence rate ratio [IRR] 0.37, 95% CI 0.19 - 0.72, 
p=0.002) and inappropriate submission of urine cultures (pre- 2.6 to post- 0.9 cultures per 1,000 resident days; 
IRR 0.36, 95% CI 0.21 - 0.62, p<0.001) decreased significantly six months post-intervention and these 
reductions were sustained for 30 months.   
 
A multidisciplinary team, including an infectious diseases consultant, an infection control nurse and a 
geriatrician, provided academic detailing concerning the diagnosis and treatment of urinary tract infections to 
head practitioners and head nurses at all long-term care facilities for older persons in Finland during 2004 to 
2005.81  After the visits, regional guidelines were developed and published and an annual questionnaire was 
mailed to the head nurse of each unit.  This multifaceted intervention was associated with a significant 
reduction in the proportion of residents on antibiotic prophylaxis for urinary tract infections (14.5% in 2005 vs. 
7.8% in 2008, p<0.001).  Most recently, a controlled, quasi-experimental study among two Veterans Affairs 
Healthcare System Medical Centers, both of which included long-term care and general medicine wards, found 
a multifaceted educational program, which included individualized feedback to clinicians, was associated with 
significant reductions in overtreatment of asymptomatic bacteriuria in intervention vs. comparison sites (long-
term care residents only; intervention period: 20% vs. 40%, maintenance period: 10% vs. 19.2%).82 
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Antimicrobial Stewardship Tool 
An antimicrobial stewardship tool for nurses in long-term care facilities was associated with significant 
decreases in total antibiotic use.55  This tool to promote appropriate use of antibiotics was a pre-printed form 
with two parts to be completed by nurses at treatment initiation and 48-72 hours after starting treatment.  Other 
educational interventions implemented included a support pack, a dedicated telephone number for the project, 
follow-up visits, posters, and promotional material.  The support pack included signs and symptoms of 
infections in elderly, obtaining clinical cultures, and information on resistance. Post-intervention there was a 
significant 4.9% decrease (95% CI 1.0% - 8.6%, p=0.02) in total antibiotic consumption in the intervention 
group (3.25 less defined daily doses per 1,000 resident days) and a 5.1% increase (95% CI 0.2%-10.2%, 
p=0.04) increase in the control group (2.42 more defined daily doses per 1,000 resident days).  Total antibiotic 
consumption for prophylaxis of infection, and appropriateness of prescribing (measured by proportion of 
residents that fully met McGreer Criteria and also by proportion of residents that fully met the minimum Loeb 
Criteria) improved post-intervention.  Additionally, no adverse events related to the tool were identified. 
 
Infectious Diseases Consult Services 
A recent quasi-experimental study assessed the impact of an infectious diseases consult service implemented 
as a 160-bed Veterans Affairs long-term care facility.87  This consult service included an infectious diseases 
physician and nurse practitioner that provided on-site weekly rounds.  The remainder of the week they were 
available for remote consultation.  This service was associated with a reduction in total antimicrobial use by 
30% (p<0.001), fluoroquinolones by 38% (p<0.001), and β-lactam/β-lactamase inhibitor combinations by 28% 
(p<0.001).  Additionally, the rate of positive C. difficile tests declined significantly post-intervention as 
compared to pre-intervention (p=0.04).  Since this was a VA facility, these findings may be not easily translated 
to community based facilities. 
 
Antibiograms 
The utility of antibiograms in improving antimicrobial use in acute care facilities is well recognized, however 
their use in long-term care facilities is relatively unknown.  Antibiograms are cumulative summaries of 
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antimicrobial susceptibilities of local bacterial isolates over a period of time, usually six months or a year.88  
Clinicians typically use antibiograms to assess local susceptibility rates, which aids in the selection of 
appropriate empiric antibiotic therapy.  One study specifically evaluated the impact of an antibiogram in a 
community-based skilled nursing facility.89  Appropriate antibiotic empiric prescribing, defined in this study as 
an antibiotic choice that sufficiently covered the infecting organism based on antibiotic susceptibilities (i.e., 
facility specific antibiogram), increased from 32% to 45% after implementing the facility-specific antibiogram 
(p=0.32). 
 
Measuring Outcomes and Metrics in Long-term Care. 
Based upon our experience with antimicrobial stewardship and our review of the literature, we have additional 
ideas on how to advance antimicrobial stewardship in long-term care, which will be discussed throughout the 
remainder of our article.  The studies conducted to date have mostly focused on the impact of antimicrobial 
stewardship programs on antimicrobial utilization.  Though this is often the easiest outcome to measure, 
overall antibiotic use alone is not the strongest surrogate endpoint for improving resident safety and clinical 
outcomes.  Declines in antibiotic use may not capture appropriate use since appropriate use means not only 
non-prescribing when an indication is absent but also proper prescribing when indicated.  Instead, change in 
use should be targeted based on areas of high resistance or overuse. Additionally, a standard definition of 
appropriate use is needed since it varies greatly in the literature. 
 
More research is needed using metrics that capture hard endpoints of resident safety and clinical outcomes 
rather than surrogate measures.  However, doing this type of research is challenging.  The studies conducted 
to date provide important foundation needed to begin to conduct this type of research in the future.  At this 
time, none of the studies reviewed assessed the impact of their intervention on antimicrobial resistance or total 
costs of care.  Few studies attempted to measure clinical outcomes, such as reductions in mortality or adverse 
events, or healthcare utilization, such as reductions in rates of emergency department visits and 
hospitalizations, as a result of improvements in appropriate antibiotic use.  Moreover, no single study was able 
to provide a comprehensive assessment of their intervention on all the important outcomes of such a program, 
including antimicrobial utilization, healthcare utilization, costs, resistance, and clinical outcomes, including 
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relevant adverse outcomes such as C. difficile infection and adverse drug events.  Finally, assessing the 
sustainability of implemented strategies is a worthy future research endeavor.   
 
Future of Antimicrobial Stewardship in Long-term Care.  
Continued research must be done to broaden the arsenal of stewardship interventions in long-term care and to 
identify the most effective strategies.  Antimicrobial stewardship guidelines for the acute care setting 
recommend a multidisciplinary approach and support from hospital leadership.7  These principles may also be 
important in the long-term care setting, but require further investigation.  Due to important differences between 
acute care hospitals and long-term care facilities, the ability to obtain financial support from leadership for 
antimicrobial stewardship multidisciplinary personnel and other resources may be challenging.  However, as 
the CDC has recently recommended, leadership should at least demonstrate their support for antimicrobial 
stewardship through written statements.14  Leadership should sign and support a written antimicrobial 
stewardship policy that should be shared with staff, residents, and families.  Additionally, leadership can 
include stewardship-related duties in position descriptions and create a culture that promotes antimicrobial 
stewardship.14  Additionally, for now, there is a call for the infection prevention control officer to work together 
with a physician or pharmacist to champion antimicrobial stewardship needs.   
 
Support and collaboration of administration and clinicians are essential to the success of any antimicrobial 
stewardship program.7  This support can be obtained through effective and local champions or leaders.72    
Champions are individuals who take ownership over the mission of the program and advocate for and support 
antimicrobial stewardship interventions.72  Champions can help empower both leadership and staff to support 
antimicrobial stewardship efforts.  The CDC recently recommended that nursing homes identify individuals 
accountable for antimicrobial stewardship to empower and engage leadership and staff.14  For facilities where 
stewardship is one of several competing priorities, an administrative champion such as the medical director 
can argue the case for antimicrobial stewardship to other medical staff leadership.  Peer clinical champion or 
champions are also critically important.  Well-respected clinicians, such as physicians, pharmacists, or nurses, 
with training in antimicrobial stewardship are ideally suited to act as peer champions.  Peer champions should 
be committed to spearheading the program, and educating and gaining acceptance of other clinicians and staff 
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on the program. Without written polices “championing” for antimicrobial stewardship action may be difficult, 
therefore the champion should consider developing policies that promote optimal antibiotic use.   
 
Many long-term care facilities across the country utilize central fill pharmacies and automated medication and 
supply systems.  A central fill pharmacy is a one that processes and fills prescriptions for several local long-
term care facilities.  Therefore, the central fill pharmacy and pharmacists at those sites can play a unique role 
in promoting appropriate antimicrobial use within the local long-term care facilities they serves.  Pharmacists 
are ideally suited to ensure that for each antimicrobial order an infectious diagnosis is documented, and can 
make recommendations on appropriate drug choice, dose and duration using a facility’s local antibiogram and 
treatment pathways.69  A clinically trained ID pharmacist’s specialized knowledge of pathogenic microbiology, 
drug-resistance, pharmacotherapy, drug-drug interactions, pharmacokinetics (i.e., absorption, metabolism, 
distribution and excretion of antibiotics) and pharmacodynamics (i.e., maximizing antimicrobial killing / activity 
profiles) allows them to meaningfully contribute to antimicrobial stewardship.  They can provide educational “in 
services”, assist in treatment pathway development, and recommend alternative antimicrobial choices at time 
of prescribing.  However, busy pharmacists at central fill locations may not have protected workload time for 
antimicrobial stewardship activities, and thus other daily responsibilities may take precedence over 
stewardship.  Additionally, the central fill pharmacy may not have access to clinically trained ID pharmacists.  
Therefore, training staff through antimicrobial stewardship certification programs may be a helpful option.  
Fortunately, there are antimicrobial stewardship certificate training programs among other informal training 
opportunities available for interested pharmacists and providers.70,71 
 
Other strategies to advance stewardship include bringing staff with antibiotic expertise to long-term care 
facilities.  Several facilities could share an infectious diseases consultant or a facility could share an infectious 
diseases consultant with a local acute care hospital to mitigate the cost of obtaining these individuals.  Federal 
agencies are likely to continue to increase antimicrobial stewardship demands on long-term facilities to 
improve the safety of residents, however resources are not likely to increase.  As such, there is a critical need 
to develop minimally sufficient and direct antimicrobial-focused interventions, which can effect significant 
reductions in inappropriate antimicrobial use with the least amount of resources.  
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Conclusion 
Antimicrobial resistance is a global public health crisis, one that has been accelerated through indiscriminant 
antimicrobial use.  Antimicrobial stewardship programs have been recommended across all facets of 
healthcare to improve antimicrobial use and combat antimicrobial resistance, however in the long-term care 
setting; effective antimicrobial stewardship interventions are largely unknown.  High prevalence of antimicrobial 
use and resistant bacteria, coupled with limited resources, plague effective antimicrobial stewardship in this 
setting.  Our review only identified fourteen studies of antimicrobial stewardship interventions in long-term care.  
Overall, the quality of evidence was weak, the results were mixed, the interventions varied greatly, as did study 
definitions and outcomes measures, such as “appropriate use”.  Several studies suggest that multifaceted 
educational interventions may be effective in increasing appropriate antimicrobial use in long-term care 
facilities.  However, there is a critical need for future well-designed studies to develop tailored interventions to 
improve the care of the 1.4 million residents of long-term care facilities across the United States. 
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Table 1:  Needs for Antimicrobial Stewardship in Long-Term Care Facilities 
Needs Identified 
High prevalence of inappropriate and unnecessary antibiotic use  
Increased risk for colonization with resistant bacteria 
Increased risk of Clostridium difficile Infections and potential complications 
 
  
26 
Table 2:  Barriers to Antimicrobial Stewardship in Long-Term Care Facilities 
Barriers Identified 
Paucity of well-validated strategies specific to long-term care facilities 
Lack of funding and facility resources, such as lack of on-site microbiology laboratories 
Challenges associated with proper diagnosis and treatment of infection in residents  
Lack of trained infectious diseases physicians and pharmacists 
Resident and family expectations  
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Table 3:  Randomized Controlled Trials to Improve Antimicrobial Use in Long-Term Care Facilities 
Study (Primary 
Author Year of 
Publication) 
Infection of Interest Design Setting Intervention Unit of 
Analysis 
Main 
Outcomes/Results 
Naughton 2001 
 
 
 
Overall findings: 
Education 
targeting 
pneumonia did 
not significantly 
change antibiotic 
use (PO or IV) or 
resident 
outcomes. 
Pneumonia 
(focus of education 
on national nursing 
home-acquired 
pneumonia 
guidelines) 
 
RCT (Pre-
Intervention period: 
Nov 1997- April 
1998; Post- 
Intervention period: 
Nov 1998- April 
1999);  
 
Unit of 
Randomization:  
- SNFs 
 
Allocation of 
randomization: 
- Physician-only 
intervention group 
 
- Multidisciplinary 
intervention group 
Ten SNFs from 
Buffalo, New 
York, United 
States (total of 
2,375 beds) 
Physician-only 
group: 
- Small-group 
consensus 
process for 
guideline 
development 
limited to 
physicians and 
nurse practitioners 
by two study 
physicians 
 
- Laminated 
pocket cards  
 
Multidisciplinary 
group: 
- 1-hour training 
session on the 
guidelines for 
nurses (RNs and 
LPNs) by two 
study nurses 
(similar to the 
small-group 
consensus 
conference)  
 
- Laminated 
pocket cards  
 
- Laminated 
posters 
- Episodes of 
pneumonia 
acquired more 
than 3 days 
after admission 
to SNF 
 
- 226 episodes 
of pneumonia 
pre- 
Intervention 
 
-116 episodes 
of pneumonia 
post- 
Intervention 
Pre- vs. Post- 
Intervention treatment 
in accordance with 
guidelines: 
- IV: 62.2% (79/127) 
vs. 73.4% (47/64), p = 
0.15 
 
-Multivariate analysis 
found significantly 
more IV use in 
accordance with 
guidelines post- 
Intervention (p < 0.02) 
 
PO: 
57.6% (57/99) vs.  
59.6% (31/52), p = 
0.86 
 
Pre- vs. Post- 
Intervention IV use in 
accordance with 
guidelines by group: 
 
- Physician-only group: 
64.5% (69/107) vs. 
69% (29/42), p=0.73 
 
- Multidisciplinary 
group: 50% (10/20) vs. 
81.8% (18/22), p=0.06 
 
-Multivariate analysis 
found no significant 
difference in IV use in 
28 
accordance with 
guidelines between 
groups (P =0.13) 
 
Physician vs. 
multidisciplinary PO 
use in accordance with 
guidelines: 
No difference (p = 
0.27) 
 
-Multivariate analysis 
found no significant 
difference in PO use in 
accordance with 
guidelines between 
groups (p =0.27) 
 
No differences in 30-
day mortality or 
hospitalization rates 
between pre- and 
post-intervention 
groups. 
Loeb 2005 
 
 
 
Overall findings: 
Educational 
interventions 
targeting UTIs 
significantly 
decreased overall 
antimicrobial use  
 
UTI Cluster RCT (NHs 
enrolled from Sept 
2001 – Feb 2002; 
last follow-up Mar 
2003);  
 
Unit of 
Randomization:  
- NHs  
 
Allocation of 
randomization: 
-Multifaceted AMS 
intervention group 
(Intervention group) 
 
- Usual care group 
24 NHs in 
Ontario, 
Canada, and 
Idaho, United 
States (12 
intervention 
homes, 12 
control homes; 
mean beds 183 
+/- 64.7) 
- Diagnostic and 
treatment 
algorithm for 
physicians and 
nurses 
 
-Small group 
interactive 
sessions for 
nurses 
 
-Videotapes 
 
-Written 
explanatory 
materials for 
physicians 
20 NHs that 
completed the 
study 
 
-Included 1,896 
residents in 
intervention 
group 
 
-Included 1,858 
residents in 
control group 
Intervention vs. control 
homes: 
-Antimicrobials for 
suspected UTIs/ 1,000 
RD: 
1.17 vs. 1.59 
(weighted mean 
difference -0.49, 95% 
CI -0.93 - -0.06) 
 
- Monthly rates of 
antimicrobial 
prescriptions for UTIs 
were lower in the 
intervention homes, 
however non-
significant trend 
29 
(Control group)  
-Large posters  
 
-Pocket cards 
 
-NH staff member 
assigned to 
remind nurses to 
use algorithm 
 
-Outreach visits 
every three 
months 
 
-One on one 
interviews with 
physicians 
towards a reduced 
effect over 12 months 
(regression coefficient 
-0.017, 95% CI -0.056 
– 0.02) 
 
- Proportion of total 
antimicrobials for 
suspected UTIs: 
28.4% vs. 38.6% 
(weighted mean 
difference -9.6%, 95% 
CI -16.9% - -2.4%).  
 
-DDD/1,000 RD for 
suspected UTIs: 
6.9 vs. 10.9 (weighted 
mean difference -3.85,  
95% CI -7.37—0.34) 
 
-Total antimicrobial 
use/ 1,000 RD:  
3.52 courses vs. 3.93 
(weighted mean 
difference -0.37, 95% 
CI -1.17 - 0.44).  
 
- Urine cultures 
obtained/1,000 RD: 
2.03 vs. 2.48 
(weighted mean 
difference -0.51, 95% 
CI -1.38-0.35) 
 
No significant 
differences in mortality 
or hospital admissions 
between intervention 
and control NHs. 
Monette 2007 
 
UTI, SSTI, lower 
respiratory tract 
Cluster RCT (Pre-
Intervention period: 
8 public LTCFs 
in Montreal, 
- Antibiotic guide 
with feedback on 
1,539 initial 
antibiotic 
Change in non-
adherent antibiotics 
30 
 
 
Overall findings: 
When provided 
with an antibiotic 
guide and 
feedback 
physicians were 
less likely to 
prescribe non-
adherent 
antibiotics. 
 
infection, and 
septicemia of 
unknown origin 
Dec 2001- Feb 
2002; Intervention 
1: Mar – April 2002;  
Post- Intervention 
period 1: May-July 
2002; Intervention 
2: Aug 2002; Post- 
Intervention period 
2: Sept-Nov 2002; 
Follow-up period: 
Dec 2002 – 
February 2003) 
 
Unit of 
Randomization:  
LTCFs 
 
Allocation of 
randomization: 
- Physicians who 
received the 
intervention 
(Intervention group) 
 
- Physicians who  
provided usual care 
(Control group) 
 
 
Canada (4 
intervention 
LTCFs; 4 
control LTCFs) 
 
prescribing 
practices over the 
previous 3 months 
mailed to 36 
physicians  
 
- Intervention 
repeated 4 
months apart 
 
prescriptions 
(1,003 
intervention; 
590 control) 
pre- to post- 
intervention between 
intervention vs. control 
homes: 
20.5% decrease vs. 
5.1% decrease  
 
Effect of the 
intervention on the 
physicians’ likelihood 
of prescribing non-
adherent antibiotics 
with the pre-
intervention period as 
reference: 
- Post- Intervention 
period 1: Intervention 
physicians 53% less 
likely to prescribe non-
adherent antibiotics 
(OR=0.47, 95% 
CI=0.21-1.05) 
-Post- Intervention 
period 2: Intervention 
physicians 64% less 
likely to prescribe non-
adherent antibiotics 
(OR=0.36, 95% CI 
=0.18-0.73) 
 
-15 months follow-up:  
Intervention physicians 
52% less likely to 
prescribe non-
adherent antibiotics 
(OR=0.48, 95% CI= 
0.23=1.02) 
Pettersson 2011 
 
All infections - Cluster RCT (Pre- 
Intervention period: 
58 NHs in 
Sweden (26 
- Small 
educational group 
46 nursing 
homes 
Effect of the 
intervention (95% CI) 
31 
 
 
 
Overall findings: 
Educational group 
sessions with 
feedback 
decreased the 
overall 
prescribing of 
antibiotics. 
 
 
Sep- Dec 2003; 
Intervention Oct 
2004 – Jan 2005; 
Post- Intervention: 
Feb – May 2005) 
 
 
Unit of 
Randomization:  
NHs 
 
Allocation of 
randomization: 
-Multifaceted AMS 
intervention group 
(Intervention group) 
 
- Usual care group 
(Control group) 
intervention 
NHs; 20 control 
NHs) 
sessions with 
nurses and 
physicians 
 
- Feedback  
 
- Presentation of 
guidelines 
 
-Written materials 
completed the 
study 
 
-Included 1,373 
residents in 
intervention 
group 
 
-Included 1,138 
residents in 
control group 
 
 
at 2 years (difference): 
 
-Proportion of 
quinolones prescribed 
for lower urinary tract 
infection: 
0.028 (-0.193 - 0.249).  
 
-Proportion of 
infections treated with 
antibiotics: 
-0.124 (-0.228, -0.019) 
 
- Proportion of 
infections handled by 
physicians as 'wait and 
see: 
0.143 (0.047, 0.240) 
 
- UTIs per resident: 
0.038 (-0.013-0.089) 
 
No differences in 
hospital admissions for 
intervention or control 
groups. 
ADE= adverse drug event; AMS= antimicrobial stewardship intervention; ASB= asymptomatic bacteriuria; CAUTI= catheter-associated urinary tract 
infection; CI= confidence interval; DDD= days daily dose; DOC= resident days of care; DOT= days of therapy; IC= infection control; ID= infectious 
diseases; IRR= incidence rate ratio; ITS= Interrupted time series analysis; IV: Intravenous antibiotic; LPN=licensed practical nurse; LTC= long-term 
care; LTCF= long-term care facility; NH=nursing home; OR= odds ratio; PA= parenteral antibiotics; PD= patient days; PO= oral antibiotics; QI= 
quality improvement; RCT=randomized, controlled trial; RD= resident days; RN= registered nurse; SNF= skilled nursing facility; SSTI=skin and soft 
structure infection; UTI= urinary tract infection; VA= Veterans Affairs 
  
32 
Table 4:  Studies to Improve Antimicrobial Use in Long-Term Care Facilities by Type of Intervention  
Study (Primary 
Author Year of 
Publication) 
Infection of Interest Design Setting Intervention Unit of 
Analysis 
Main 
Outcomes/Results 
Multifaceted Educational Interventions Targeting General Antibiotic Use for All Infection Types. 
Interventions Targeting Providers Only. 
Monette 2007 See Table 3 
Schwartz 2007 
 
 
 
Overall findings: 
Educational 
sessions with  
feedback 
improved 
appropriate 
treatment and 
decreased 
antimicrobial use. 
 
All infections Uncontrolled Quasi-
experimental Study 
(Pre-Intervention 
period: Jan – Oct 
2000; Post- 
Intervention period: 
May– Sept 2002) 
Public LTC and 
acute care 
hospital (340 
LTC beds) in 
Illinois, United 
States 
 
- Four educational 
sessions to 20 
internists given by 
ID specialists 
(included national 
guidelines, 
hospital 
resistance data, 
and physician 
feedback) 
 
- Pocket-sized 
booklets, 
algorithms, 
guidelines 
 
- 200 randomly 
selected 
residents 
treated with 
antimicrobials 
(100 pre- 
Intervention; 
100 post- 
Intervention) 
Antibiotic use 
compliant with 
guidelines pre- vs 
post-Intervention: 
 
-Initial treatment 
agreed with guidelines: 
11% vs. 39%, p<0.001 
 
-Clinical criteria agreed 
with guideline 
diagnostic criteria: 
62% vs. 32%, p = 
0.006 
 
Interrupted time series 
analysis of the effect of 
the interventions on 
antimicrobial use 
during the 1.5 year 
intervention period and 
2 year post-
intervention. 
 
Antimicrobial use:  
Decreased 29.7%; 
sustained during the 
post-intervention 
period (ITS 
demonstrated reduced 
level and slope during 
intervention period 
was significant, 
33 
p<0.001) 
 
 - Antimicrobial starts: 
Decreased 25.9%; 
sustained during the 
post-intervention 
period (ITS 
demonstrated reduced 
level and slope during 
intervention period but 
this was not 
significant) 
 
No significant 
differences in all-cause 
and infection related 
mortality. 
Interventions Targeting Providers and Nurses. 
Pettersson 2011 See Table 3 
Zimmerman 2014 
 
 
 
Overall findings: 
A QI program with 
educational 
sessions and 
feedback 
decreased overall 
antimicrobial 
prescribing rates 
and prescribing 
rates for 
respiratory tract 
infections.  
UTI, SSTI, 
respiratory infections, 
and non-infectious 
vomiting/diarrhea 
Controlled Quasi-
experimental Study 
(Pre- Intervention 
Period: Mar – May 
2011, Post- 
Intervention period: 
June – Nov 2011) 
12 NHs in North 
Carolina, United 
States (6 
intervention 
NHs [mean 
beds 146 +/- 
37.1]; 6 control 
NHs [mean 
beds 124 +/- 
22.2]) 
QI program: 
- Educational 
sessions to 
providers and 
nurses by a 
physician, nurse, 
ID specialist, ands 
experts in LTC 
 
- Medical care 
referral form and 
pocket card 
 
-Monthly feedback 
on prescribing to 
prescribers and 
nurses 
 
- Informational 
brochure and 
meetings for 
nursing home 
All residents, 
including 1,497 
residents 
treated with 
antibiotics 
Effect of intervention 
on antibiotic 
prescribing rates 
between pre- and 
post-Intervention 
periods for intervention 
vs. control NHs: 
-Total antibiotics for all 
infections: IRR 0.86, 
95% CI 0.79-0.95, 
p<0.05 
 
- Antibiotics for 
respiratory infections: 
IRR 0.71, 95% CI 
0.56-0.90, p<0.05 
 
- Antibiotics for UTIs: 
IRR 0.84, 95% CI 
0.66-1.05, p>0.05 
 
- Antibiotics for SSTI: 
34 
staff, residents, 
and families 
IRR 0.89, 95% CI 
0.62-1.28, p>0.05 
Multifaceted Educational Interventions Targeting Antibiotic Use for Pneumonia. 
Naughton 2001 See Table 3 
Hutt 2006 
 
 
 
Overall findings:  
Educational 
sessions and 
academic 
detailing for 
pneumonia not 
associated with 
significant 
improvements in 
antibiotic choice 
or timing in 
intervention 
homes. 
Pneumonia 
(focus of education 
on national nursing 
home-acquired 
pneumonia 
guidelines) 
 
Controlled Quasi-
experimental Study 
(Pre- Intervention 
Period: Nov 2003-
Apr 2004, Post- 
Intervention Period: 
Nov 2004 - Apr 
2005)  
Two State 
Veterans Home 
in Colorado, 
United States (1 
intervention NH 
[134-beds]; 1 
control NH 
[120-beds]) 
- Interactive 
educational 
sessions for 
nurses 
 
- Toolkit 
(Annotated copy 
of guidelines, 
case studies, 
preprinted orders, 
pocket card with 
guidelines 
reminders, and 
posters) 
disseminated  
throughout facility 
 
- Academic 
detailing to 
physicians and 
providers 
86 residents 
with two or 
more signs of 
lower 
respiratory tract 
infections (46 
intervention 
group; 40 
control group) 
Change in guideline 
compliant antibiotics 
pre- to post-
Intervention in 
intervention homes: 
 
- Antibiotic choice: 
63% vs. 81%, p >0.05 
 
- Timely antibiotic:  
88% vs. 79%, p >0.05 
 
Guideline compliant 
antibiotics in 
intervention homes vs 
control homes during 
Post-Intervention 
Period: 
 
- Antibiotic choice: 
81% vs. 33%, p <0.05 
 
- Timely antibiotic:  
79% vs. 17%, p <0.05 
 
No significant 
differences in mortality 
or hospitalization rates 
between intervention 
and control groups. 
 
No significant 
differences in mortality 
or hospitalization rates 
between pre- and 
post- periods. 
Linnebur 2011 Pneumonia Controlled Quasi- Sixteen NHs in - Educational 1,123 episodes Difference in change 
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Overall findings:  
Educational 
sessions and 
academic 
detailing or 
pneumonia 
improved timing 
but not choice of 
antibiotics.   
 
(focus of education 
on national nursing 
home-acquired 
pneumonia 
guidelines) 
experimental Study 
(Pre- Intervention 
Period: Oct 2004 – 
Apr 2005, Post- 
Intervention Period: 
Oct 2005- Apr 2006 
and Oct 2006- Apr 
2007) 
Colorado (8 
intervention 
NHs [mean 
beds 134] ) and 
Kansas, United 
States (8 control 
NHs [mean 
beds 128]) 
sessions  for 
nurses 
 
- Academic 
detailing to 
prescribers by 
pharmacists 
regarding 
diagnostic and 
prescribing 
practices 
of pneumonia 
evaluated (549 
intervention 
group; 574 
control group) 
pre- and post- 
intervention of 
antibiotic use 
compliant with 
guidelines between 
intervention vs. control 
homes: 
 
Antibiotic choice: 
6% increase vs 7% 
increase, p=0.3 
 
Antibiotic duration: 
14% decrease vs. 5% 
increase, p>0.05 
 
Timely antibiotic:  
18% increase vs. 7% 
decrease, p=0.0003 
 
No significant 
differences in mortality 
between intervention 
and control groups. 
Multifaceted Educational Interventions Targeting Antibiotic Use for Suspected Urinary Tract Infections. 
Loeb 2005 See Table 3 
Zabarsky 2008 
 
 
 
Overall findings:  
Educational 
sessions with 
feedback for ASB 
decreased 
treatment for ASB 
and inappropriate 
urine cultures.    
 
ASB Uncontrolled Quasi-
experimental Study 
(Pre-Intervention 
period: 3 months, 
Post- Intervention 
period 30 months; 
Feb 2002 – Oct 
2004) 
VA Medical 
Center in 
Cleveland, 
Ohio, United 
States (190 LTC 
beds) 
- Educational 
sessions to 
nurses and 
providers 
conducted by an 
IC nurse and ID 
physician  
 
-Pocket-sized 
reference cards, 
larger cards at 
each computer 
station 
 
-Semi-annual 
 Pre-Intervention vs. 6 
months post and vs. 
30 months post: 
 
Antibiotic regimens for 
ASB: 
68% vs. 69%, p=0.90 
vs. 44%, p=0.022 
 
ASB treated/1,000 PD 
days: 
1.7 à 0.6 (IRR 0.37, 
95% CI 0.19-0.72, 
p=0.002) à 0.3   
 
36 
follow up 
educational 
sessions 
 
- Individualized 
direct feedback for 
nurses and 
providers 
Total antibiotic days 
DOT/1,000 PD:  
167.7 à 117.4 
(p<0.001) à 109 
(p<0.001) 
 
Inappropriate cultures:  
69% vs. 61% vs. 46% 
 
Inappropriate cultures 
sent/1,000 PD: 
2.6 à 0.9 (IRR 0.36, 
95% CI 0.21-0.62, 
p<0.001) à 0.6 
Rummukainen 
2013 
 
 
 
 
Overall findings:  
Academic 
detailing 
decreased 
proportion of 
residents on 
antibiotic 
prophylaxis for 
UTI. 
 
UTI prophylaxis Uncontrolled Pre- 
(2005 baseline 
visit) vs. Post 
(2006, 2007, 2008 ) 
surveys  
25 primary care 
hospitals and 39 
NHs in Finland  
- Academic 
detailing to head 
practitioners and 
head nurses (by 
an ID consultant, 
IC nurse, and 
geriatrician) 
 
- Regional 
guidelines 
 
- Annual surveys 
to reinforce 
guidelines 
68 units visited 
and responded 
to surveys 
The proportion of 
residents on antibiotic 
prophylaxis for UTI: 
14.5% in 2005 to 7.8% 
2008, p<0.001 
Trautner 2015 
 
 
 
Overall findings:  
Educational 
sessions, 
feedback, and a 
diagnostic 
algorithm 
targeting ASB 
ASB Controlled Quasi-
experimental Study 
(Pre-Intervention 
period: July 2010 – 
June 2011; 
Intervention Period: 
July 2011- June 
2012; Maintenance 
Period: July 2012 – 
June 2013) 
Two VA Health 
Care System 
Medical Centers 
in Texas, United 
Sates 
(1intervention 
center in 
Houston [5 
general 
medicine and 5 
LTC wards 
- CAUTI vs. ASB 
diagnostic 
algorithm  
 
- Case-based 
individualized 
audit and 
feedback to train 
clinicians to use 
algorithm  
 
 LTC Residents Only: 
 
Overtreatment of ASB 
lower during the 
intervention (OR 0.23, 
95% CI 0.08-0.65) and 
maintenance (OR 
0.10, 95% CI 0.01-
0.84) periods at the 
intervention facility. 
 
37 
reduced 
overtreatment of 
ASB. 
 
included], 1 
control center in 
San Antonio [3 
general 
medicine and 2 
LTC wards 
included]); 
United States 
- Educational 
sessions to 
practitioners and 
nurses by 
Principal 
investigator (MD, 
PhD) 
 
Overtreatment of ASB 
higher during the 
intervention 
 (OR 9.67, 95% CI 
1.43-65.38) and similar 
for the maintenance 
(OR 3.45, 95% CI 
0.61-19.53) periods at 
the control facility. 
 
All subjects: 
Significant decrease in 
the number of urine 
cultures ordered per 
month over time when 
comparing 2 sites 
(p<0.001) 
Implementation of a Novel Antimicrobial Stewardship Tool.  
Fleet 2014 
 
 
 
Overall findings:  
Antimicrobial 
stewardship tool 
decreased 
antibiotic use and 
improved 
appropriate 
treatment. 
 
All infections Cluster RCT (Pre- 
Intervention period: 
Jan– May 2010; 
Post- Intervention 
period: Jan– May 
2011 Post) 
 
Unit of 
Randomization:  
- NHs  
 
Allocation of 
randomization: 
- AMS Tool group 
(Intervention group) 
 
- Usual care group 
(Control group) 
30 NHs in 
London, 
England (15 
intervention 
NHs,15 control 
homes [total of 
1,832 beds in 
both groups]) 
- Antimicrobial 
stewardship tool 
(pre-printed form) 
for nurses 
 
-Support pack for 
nursing staff and 
managers 
 
-Dedicated 
telephone number 
for the project 
 
-Follow-up visits 
 
- Posters and 
promotional 
material 
3,328 residents 
(1,663 
intervention, 
1,575 control)  
Intervention vs. control 
homes: 
 
Change in total 
antibiotic consumption 
pre. vs. post: 
I4.9% decrease (3.25 
DDD/1,000 RD, 95% 
CI 1.0% - 8.6%, 
p=0.02, intervention 
group) 
 
5.1% increase (2.42 
DDD/1,000 RD, 95% 
CI 0.2% - 10.2%, 
p=0.04, control group) 
 
Change in total 
antibiotic consumption 
for prophylaxis pre. vs. 
post: 
2.72 DDD/1,000 RD 
38 
decrease (intervention 
group) 
 
0.83 DDD/1,000 RD 
increase (control 
group) 
 
Proportion of residents 
that fully met “McGreer 
Criteria’ post- 
intervention between 
intervention vs. control 
homes: 
11.1% vs. 2.6%, 
p=0.004 (estimated 
relative increase 6.44) 
 
Proportion of residents 
that fully met “Loeb 
minimum Criteria’ 
post- intervention 
between intervention 
vs. control homes: 
19.3% vs. 5.1%, 
p=0.001 
 
No ADEs due to tool. 
Implementation of an Infectious Diseases Consultation Service. 
Jump 2012 
 
 
 
Overall findings:  
ID consult service 
decreased 
antibiotic use and 
of rate of positive 
C. difficile tests 
 
All infections Uncontrolled Quasi-
experimental Study 
(Pre-ID Service 
Period: July 2006–
June 2009, Post-ID 
Service Period: July 
2009–Dec 2010) 
VA LTCF in 
United States 
(160-beds)  
ID consult service 
that consisted of 
an ID physician 
and a nurse 
practitioner who 
examined 
residents at the 
LTCF once each 
weekly and the 
remainder of the 
week were 
available for 
remote 
Antibiotic DOT/ 
1,000 DOC 
 
C. difficile tests/ 
1,000 DOC 
  
Pre-vs. Post-ID 
Consult: 
 
- Total systemic 
antibiotic mean 
DOT/1,000 DOC: 
175.1 vs.122.3, 
p<0.001 (30.1% 
decrease) 
 
- Rate of positive C. 
difficile tests declined 
in the post-period 
39 
consultation (via 
telephone and the 
electronic medical 
record) 
relative to pre-period 
rates, p=0.04 
 
- Hospital Transfers 
Per Month:  
19.0 vs. 17.6, p=0.27 
Implementation of an Antibiogram. 
Furuno 2014 
 
 
 
Overall findings:  
Antibiogram non-
significantly 
increased 
appropriate 
empiric 
prescribing. 
All infections Uncontrolled Quasi-
experimental Study 
(Pre-antibiogram 
Period: 6 months, 
Post-antibiogram 
Period: 6 months)  
Three SNFs in 
Maryland, 
United States  
(Antibiogram 
effectiveness 
assessed a 
single SNF 
[118-beds]) 
-Antibiogram 
 
-Educational in-
services 
(introduction of 
the antibiogram 
and explanation of 
how to use to use 
the tool) to 
nursing staff, 
administrators, 
nurse managers, 
and physicians by 
study staff 
839 resident 
charts reviewed 
to inform the 
antibiograms  
Pre- vs. Post-
antibiogram 
prevalence of 
appropriate empiric 
antibiotic prescribing: 
32% vs. 45%, p=0.32 
ADE= adverse drug event; AMS= antimicrobial stewardship intervention; ASB= asymptomatic bacteriuria; CAUTI= catheter-associated urinary tract 
infection; CI= confidence interval; DDD= days daily dose; DOC= resident days of care; DOT= days of therapy; IC= infection control; ID= infectious 
diseases; IRR= incidence rate ratio; ITS= Interrupted time series analysis; IV: Intravenous antibiotic; LPN=licensed practical nurse; LTC= long-term 
care; LTCF= long-term care facility; NH=nursing home; OR= odds ratio; PA= parenteral antibiotics; PD= patient days; PO= oral antibiotics; QI= 
quality improvement; RCT=randomized, controlled trial; RD= resident days; RN= registered nurse; SNF= skilled nursing facility; SSTI=skin and soft 
structure infection; UTI= urinary tract infection; VA= Veterans Affairs 
 
